|
Where Are These Supplements Available? |
|
Commonly Asked
Questions |
| |
|
|
|
Two formulas from major pharmaceutical
manufacturers exist which exactly duplicate the formula in the Age Related Eye
Disease Study. For information regarding the manufacturers and availability
of these vitamin, CLICK HERE. |
|
What is
AMD?
Other Resources
Home Page |
| |
|
|
|
Which Vitamin are Important? |
|
Will taking
vitamin prevent this problem? |
| |
|
|
|
Specific ingredients and amounts were found to slow the progression in those
patients with intermediate or advanced disease. It is believed that macular
degeneration vitamin contain specific anti-oxidants and Zinc that promote the
continued health of the retina and tissues surrounding the retina. |
|
In the absence of
any findings, there is no research published that shows that
taking vitamin can prevent this disease. However, the
AREDS
study did show, if there was disease in only one eye, that
taking proper vitamin supplements prevented or slowed the progress of the
disease in the opposite eye. |
© 2002 Macular Degeneration Institute
|
| |
|
High doses of certain dietary supplements
provide the first effective treatment for the leading cause of vision loss
among the elderly, a new nationwide clinical study has concluded. The disease, macular degeneration,
destroys the central portion of the retina, the light-gathering cells at the
back of the eye. Among people who already have significant yellowish
deposits accumulating at the back of their eyes — the hallmark of the
disease — the supplements cut their risk of vision loss by one-fifth. The
vitamin supplements — a combination of zinc and the antioxidants vitamin C,
vitamin E and beta-carotene — did not appear to slow the early stages of the
disease, when the yellowish deposits develop, but that is a normal part of
aging and is not necessarily of concern.
Among those whose disease had progressed to the
intermediate stage, the zinc supplements reduced by 11 percent the risk of
the disease progressing to the advanced stage, and the antioxidants reduced
the risk by 10 percent. When the two were combined, the risk dropped by 19
percent. The study followed the participants for 6.5 years on average.
|
|
|